Limiting Cost-sharing on Drugs: A Big PhRMA Objective from Health Reform

Preventing big out-of-pocket expenditures by patients for health services and pharmaceuticals may be the antidote to the toxic bad publicity for health reform during August. At least, PhRMA hopes so. The trade association is helping to support an AMA campaign against copays.

Cole Werble

PhRMA enters the final round of Health Care Reform 2009 next week with two big victories in hand and a...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet